Endocrine side effects during cancer treatment. Lecture for practitioners

Targeted therapy and immune checkpoint inhibitors (ICI) are increasingly being used to treat many solid tumors. The use alpelisib and ICPI has a risk of side-effects, particularly endocrine dysfunctions. In this lecture, there are clearly stated: initial screening, monitoring, selection of therapy a...

Full description

Bibliographic Details
Main Authors: Anastasiya A. Glibka, Natalya V. Mazurina, Ekaterina A. Troshina
Format: Article
Language:Russian
Published: ZAO "Consilium Medicum" 2022-08-01
Series:Consilium Medicum
Subjects:
Online Access:https://consilium.orscience.ru/2075-1753/article/viewFile/109885/84128
_version_ 1811320494471774208
author Anastasiya A. Glibka
Natalya V. Mazurina
Ekaterina A. Troshina
author_facet Anastasiya A. Glibka
Natalya V. Mazurina
Ekaterina A. Troshina
author_sort Anastasiya A. Glibka
collection DOAJ
description Targeted therapy and immune checkpoint inhibitors (ICI) are increasingly being used to treat many solid tumors. The use alpelisib and ICPI has a risk of side-effects, particularly endocrine dysfunctions. In this lecture, there are clearly stated: initial screening, monitoring, selection of therapy and emergency situations for each endocrinopathy, i.e. hyperglycemia during treatment with alpelisib and destructive thyroiditis and hypophysitis during treatment of ICI.
first_indexed 2024-04-13T13:00:31Z
format Article
id doaj.art-60f253993f974061b36db8b0df1419b4
institution Directory Open Access Journal
issn 2075-1753
2542-2170
language Russian
last_indexed 2024-04-13T13:00:31Z
publishDate 2022-08-01
publisher ZAO "Consilium Medicum"
record_format Article
series Consilium Medicum
spelling doaj.art-60f253993f974061b36db8b0df1419b42022-12-22T02:45:55ZrusZAO "Consilium Medicum"Consilium Medicum2075-17532542-21702022-08-0124641642110.26442/20751753.2022.6.2016954568Endocrine side effects during cancer treatment. Lecture for practitionersAnastasiya A. Glibka0https://orcid.org/0000-0002-7324-8344Natalya V. Mazurina1https://orcid.org/0000-0001-8077-9381Ekaterina A. Troshina2https://orcid.org/0000-0002-8520-8702Endocrinology Research CentreEndocrinology Research CentreEndocrinology Research CentreTargeted therapy and immune checkpoint inhibitors (ICI) are increasingly being used to treat many solid tumors. The use alpelisib and ICPI has a risk of side-effects, particularly endocrine dysfunctions. In this lecture, there are clearly stated: initial screening, monitoring, selection of therapy and emergency situations for each endocrinopathy, i.e. hyperglycemia during treatment with alpelisib and destructive thyroiditis and hypophysitis during treatment of ICI.https://consilium.orscience.ru/2075-1753/article/viewFile/109885/84128hyperglycemiadestructive thyroiditishypophysitisalpelisibimmune checkpoint inhibitors
spellingShingle Anastasiya A. Glibka
Natalya V. Mazurina
Ekaterina A. Troshina
Endocrine side effects during cancer treatment. Lecture for practitioners
Consilium Medicum
hyperglycemia
destructive thyroiditis
hypophysitis
alpelisib
immune checkpoint inhibitors
title Endocrine side effects during cancer treatment. Lecture for practitioners
title_full Endocrine side effects during cancer treatment. Lecture for practitioners
title_fullStr Endocrine side effects during cancer treatment. Lecture for practitioners
title_full_unstemmed Endocrine side effects during cancer treatment. Lecture for practitioners
title_short Endocrine side effects during cancer treatment. Lecture for practitioners
title_sort endocrine side effects during cancer treatment lecture for practitioners
topic hyperglycemia
destructive thyroiditis
hypophysitis
alpelisib
immune checkpoint inhibitors
url https://consilium.orscience.ru/2075-1753/article/viewFile/109885/84128
work_keys_str_mv AT anastasiyaaglibka endocrinesideeffectsduringcancertreatmentlectureforpractitioners
AT natalyavmazurina endocrinesideeffectsduringcancertreatmentlectureforpractitioners
AT ekaterinaatroshina endocrinesideeffectsduringcancertreatmentlectureforpractitioners